World Vaccine Congress Lyon - Terrapinn's 11th Annual Congress
- PMID: 19943212
World Vaccine Congress Lyon - Terrapinn's 11th Annual Congress
Abstract
The 11th Annual World Vaccine Congress, held in Lyon, included topics covering new therapeutic developments in the field of vaccines. This conference report highlights selected presentations on the role of big pharma in vaccine development, the future direction of vaccine R&D, influenza preparedness in Europe, and vaccines for Staphylococcus aureus, CMV and cancer. Investigational drugs discussed include an H5N1 influenza vaccine program from Baxter International Inc/DynPort Vaccine Co LLC, FP-01 (Immune Targeting Systems Ltd), FluGEM (Mucosis BV), a nonstructural protein-1-altered live-attenuated influenza vaccine candidate from Vivaldi Biosciences Inc, PentaStaph (GlaxoSmithKline plc) and StaphVAX (Nabi Biopharmaceuticals), VCL-CB01 (Vical Inc) and astuprotimut-r (GlaxoSmithKline).
Similar articles
-
Terrapinn's world influenza congress Europe 2009. Part 2.IDrugs. 2010 Feb;13(2):78-9. IDrugs. 2010. PMID: 20127556
-
Terrapinn's world influenza congress Europe 2009. Part 1.IDrugs. 2010 Feb;13(2):76-7. IDrugs. 2010. PMID: 20127555
-
International Drug Discovery Science and Technology--BIT's Seventh Annual Congress.IDrugs. 2010 Jan;13(1):23-5. IDrugs. 2010. PMID: 20024843
-
Pandemic H5N1 influenza vaccine development: an update.Expert Rev Vaccines. 2008 Mar;7(2):241-7. doi: 10.1586/14760584.7.2.241. Expert Rev Vaccines. 2008. PMID: 18324892 Review.
-
New vaccine approaches for seasonal and pandemic influenza.Vaccine. 2008 Nov 18;26(49):6232-6. doi: 10.1016/j.vaccine.2008.07.022. Epub 2008 Jul 30. Vaccine. 2008. PMID: 18674583 Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous